cmv vaccine
Vaccineexperimental
Clinical trial activity
5 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2004 (NCT00159055)
Timeline
Indications
Mechanism of action
- CytomegalovirusImmunity, active
Cytomegalovirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cmv vaccine
- towne cmv vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01195571 | Phase 1 | Sep 1, 2010 | CMV Research Foundation, International AIDS Vaccine Initiative, Virginia Commonwealth University |
| NCT00201448 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2007 | CMV Research Foundation, Virginia Commonwealth University |
| NCT00373412 | Phase 1 | Oct 1, 2006 | University of California, San Francisco, Vical |
| NCT00370006 | Phase 1 | Sep 1, 2006 | University of California, San Francisco, Vical |
| NCT00159055 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2004 | Hebrew University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CMV Research Foundation | Academic/Hospital | 2 | 1 | 2 | 2007 |
| University of California, San Francisco | Academic/Hospital | 2 | 2 | 1 | 2006 |
| Vical | For profit | 2 | 0 | 1 | 2006 |
| Virginia Commonwealth University | Academic/Hospital | 2 | 1 | 2 | 2007 |
| Hebrew University | Academic/Hospital | 1 | 1 | 1 | 2004 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2010 |
6 organizations
Page 1 / 1